More than a quarter of a century ago Robert Furchgoldltt demonstrated that removing the endothelial layer from the isolated aorta of a rabbit prevents normal relaxation in response to acetylcholine. 1 The ability of the endothelium to elicit relaxation was soon extended to more relevant physiological stimuli (adenosine triphosphate, bradykinin and serotonin). 2, 3 The endothelial cells cause arterial relaxation by releasing a powerful vasoactive substance(s) that diffuses to the underlying layers of vascular smooth muscle and thus was termed endothelium-derived relaxing factor (EDRF). EDRF that NO is involved in many aspects of biology. 8 However, in the years that followed it also became evident that endothelial cells can affect the tone of the underlying smooth muscle in more than one way. [9] [10] [11] [12] [13] [14] [15] This article focuses on NO because its reduced production characterises endothelial dysfunction, which is the first step (at least in the author's mind) in the long chain of events that leads to atherosclerosis and coronary disease. 9, [16] [17] [18] [19] The Protective Role of the Endothelium The release of NO plays an essential role in the protection exerted by the endothelial cells against coronary disease. Indeed, the endothelial mediator not only prevents abnormal constrictions (vasospasm) of the coronary arteries, but also inhibits the aggregation of platelets, the expression of adhesion molecules at the surface of the endothelial cells and, hence, the adhesion and penetration of white blood cells (macrophages) and the release and action of the vasoconstrictor and mitogenic peptide endothelin-1 (see Figure 1) . The protective release of NO is exacerbated by the local presence of factors involved in the coagulation of the blood, in particular the formation of thrombin and the aggregation of platelets. If this protective role of NO fails, the stage is set for the inflammatory response that will eventually lead to the formation of atherosclerotic plaques. 9, [16] [17] [18] [19] [20] [21] [22] The protective role played by the endothelial cells against unwanted coagulation has been demonstrated repeatedly not only in vitro 3,23-26 but also in vivo. 27 If constricted isolated animal or human coronary arteries with healthy endothelium are exposed to thrombin or aggregating platelets, they relax immediately because of the endothelial release of NO. If the endothelium has been removed, this relaxation is no longer observed, and the aggregating platelets induce vigorous constrictions as a result of their liberation of thromboxane A 2 and serotonin (5-hydroxytryptamine). When aggregating human platelets were added to the solution, vasospasm occurred in the arteries without endothelium. Thus, the healthy endothelium appears to protect blood vessels from vasospasm when they are threatened by aggregating platelets, thrombin or the arrival of a thrombus.
The Protective Role of the Endothelium
The release of NO plays an essential role in the protection exerted by the endothelial cells against coronary disease. Indeed, the endothelial mediator not only prevents abnormal constrictions (vasospasm) of the coronary arteries, but also inhibits the aggregation of platelets, the expression of adhesion molecules at the surface of the endothelial cells and, hence, the adhesion and penetration of white blood cells (macrophages) and the release and action of the vasoconstrictor and mitogenic peptide endothelin-1 (see Figure 1) . The protective release of NO is exacerbated by the local presence of factors involved in the coagulation of the blood, in particular the formation of thrombin and the aggregation of platelets. If this protective role of NO fails, the stage is set for the inflammatory response that will eventually lead to the formation of atherosclerotic plaques. 9, [16] [17] [18] [19] [20] [21] [22] The protective role played by the endothelial cells against unwanted coagulation has been demonstrated repeatedly not only in vitro 3, [23] [24] [25] [26] but also in vivo. 27 If constricted isolated animal or human coronary arteries with healthy endothelium are exposed to thrombin or aggregating platelets, they relax immediately because of the endothelial release of NO. If the endothelium has been removed, this relaxation is no longer observed, and the aggregating platelets induce vigorous constrictions as a result of their liberation of thromboxane A 2 and serotonin (5-hydroxytryptamine). When aggregating human platelets were added to the solution, vasospasm occurred in the arteries without endothelium. Thus, the healthy endothelium appears to protect blood vessels from vasospasm when they are threatened by aggregating platelets, thrombin or the arrival of a thrombus.
The two most important substances released by aggregating platelets that trigger the activation are serotonin and adenosine diphosphate (ADP). The former is dominant and stimulates 5-HT 1D serotonergic receptors of the endothelial cell membrane. ADP is a relatively minor contributor that acts on P 2y purinergic receptors. These two products trigger distinct signalling cascades in the endothelial cells (see Figure   1 ). The stimulation of serotonergic receptors (and of those for thrombin) is coupled to the activation of eNOS through pertussis toxin-sensitive Gi-proteins, and purinergic receptors follow a Gqdependent cascade. [25] [26] [27] [28] [29] If platelet aggregation were to occur in a coronary artery with a normal endothelium, the release of serotonin (and ADP) and the local initiation 
Positive Modulation of Endothelial Responsiveness
Both acute and chronic increases in flow and the resulting increasing force of shearing (shear stress) of the blood on the endothelial cells augment the release of EDRF. [30] [31] [32] [33] [34] In the coronary circulation the effect of shear stress involves the local production of the autacoid bradykinin, which stimulates the release of NO through a Gq-dependent mechanism. [25] [26] [27] [28] [29] 35, 36 The chronic effect of shear stress involves an upregulation of eNOS in the endothelial cells, leading to a greater release of NO. This then explains the repeatedly demonstrated beneficial effects of regular exercise on endothelial function. [37] [38] [39] [40] [41] In ovariectomised animals the reintroduction of physiological levels of 17 β-estradiol potentiates endothelium-dependent relaxation of the isolated arteries. 42 The potentiating effect of oestrogens on the release of NO has been confirmed repeatedly and involves both non-genomic and genomic (upregulation of eNOS) effects. In the coronary artery the potentiation is seen only with stimuli that activate Gi-coupled receptors on the endothelial cells. 43 It is counteracted by progesterone. 43 The potentiating effect of oestrogens on the release of NO by the endothelium helps to explain why women are protected against coronary disease, at least until the age of menopause. The opposing effects of oestrogens and progesterone on endothelial function may help to explain why hormone replacement therapy has not always had the expected beneficial effect on the occurrence of cardiovascular events.
Dietary factors also affect the ability of endothelial cells to release NO.
Thus, the chronic intake of ω3-unsaturated fatty acids augments the endothelium-dependent relaxation of isolated coronary arteries to aggregating platelets and other stimuli. [44] [45] [46] [47] This augmentation of endothelial function is also observed in the human circulation. The same holds true for the intake of polyphenols, whether present in red wine, green tea or dark chocolate. [48] [49] [50] [51] [52] [53] [54] [55] [56] 
Negative Modulation of Endothelial Responsiveness
Unfortunately, with increasing age the endothelium has a reduced capacity to release NO, as has been demonstrated repeatedly both in animals and in people. 18, 57 There is an overwhelming amount of data demonstrating that smoking, both chronically and acutely, inhibits the expression of eNOS and thus the ability of the endothelium to release NO.
More recently, it also became obvious that chronic exposure to polluted air and intermittent hypoxia (obstructive sleep apnoea) reduce endothelium-dependent responsiveness. 58, 59 Dietary factors can have a negative impact on endothelial function. Thus, in animals a chronic hypercholesterolaemic diet blunts endotheliumdependent responsiveness. 60, 61 In humans hypercholesterolaemia is associated with endothelial dysfunction, and normalisation of the cholesterol level (e.g. following treatment with statins) in the blood restores the response. 62, 65 These observations are in line with the studies demonstrating that obese humans exhibit reduced responses to endothelium-dependent vasodilators. 66 Diseases that constitute major risk factors of coronary disease are also accompanied by an abnormal function of the endothelium. Thus, diabetes has long been associated with impaired arterial endothelium-dependent relaxation. 67 Likewise, the endothelium-dependent relaxation is reduced in isolated arteries from different animal models of hypertension, as is the response of endothelium-dependent vasodilators in hypertensive humans. [68] [69] [70] [71] However, both in diabetes and in hypertension, the reduced endothelium-dependent relaxation/vasodilatations are not due solely to a diminished release of NO but also to the augmented production by the endothelial cells of vasoconstrictor prostanoids. 12 
Regenerated Endothelial Cells
Under normal conditions mature endothelial cells remain quiescent for many years because they are in mutual physical contact (contact in Gi-protein-mediated responses and the resulting inability to respond to serotonin and thrombin, setting the atherosclerotic process in motion (see Figure 2 ).
It would be naïve to claim that this is the only negative effect of oxLDL that obviously plays a central role in the atherosclerotic process. [85] [86] [87] It has a direct inhibitory effect on the expression and activity of eNOS. 88, 89 It also enhances the activity of arginase, which competes with NO for the common substrate arginine. [90] [91] [92] A greater production of superoxide anions will reduce the bioavailability of NO and increase the levels of peroxynitrite. 89, [93] [94] [95] A number of other genomic factors and endogenous mediators may accelerate or contribute to the atherosclerotic process. 78, [96] [97] [98] [99] However, the ultimate result is that the endothelial cells cannot produce enough NO in response to platelets and thrombin and allow the inflammatory reaction leading to atherosclerosis. 100 
Conclusions

